切换至 "中华医学电子期刊资源库"

中华介入放射学电子杂志 ›› 2013, Vol. 01 ›› Issue (01) : 36 -40. doi: 10.3877/cma.j.issn.2095-5782.2013.01.010

神经介入

Wingspan支架治疗症状性大脑中动脉M1段重度狭窄的并发症分析
蔡栋阳1, 王子亮1, 李天晓1,(), 贺迎坤1, 许斌1, 吴立恒1, 朱良付1   
  1. 1.450003 郑州,河南省人民医院介入科
  • 收稿日期:2013-06-30 出版日期:2013-08-01
  • 通信作者: 李天晓

Peri-procedural complications of stenting with Gateway-Wingspan system for symptomatic middle cerebral artery high-grade stenosis

Dong-yang CAI1, Zi-liang WANG1, Tian-xiao LI1,(), Ying-kun HE1, Bin XU1, Li-heng WU1, Liang-fu ZHU1   

  1. 1.Department of Interventional,Henan Province People's hospital,Zhengzhou 450003,China
  • Received:2013-06-30 Published:2013-08-01
  • Corresponding author: Tian-xiao LI
引用本文:

蔡栋阳, 王子亮, 李天晓, 贺迎坤, 许斌, 吴立恒, 朱良付. Wingspan支架治疗症状性大脑中动脉M1段重度狭窄的并发症分析[J]. 中华介入放射学电子杂志, 2013, 01(01): 36-40.

Dong-yang CAI, Zi-liang WANG, Tian-xiao LI, Ying-kun HE, Bin XU, Li-heng WU, Liang-fu ZHU. Peri-procedural complications of stenting with Gateway-Wingspan system for symptomatic middle cerebral artery high-grade stenosis[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2013, 01(01): 36-40.

目的

研究Wingspan支架治疗症状性大脑中动脉重度狭窄的并发症。发生原因及防治措施。

方法

回顾性分析2008年2月至2012年5月,河南省人民医院介入治疗中心应用Wingspan支架治疗的102例症状性大脑中动脉M1段重度狭窄患者的临床资料,观察术中及术后30 d内出现的不良事件,分析其发生的原因。将术者早期完成的40例定义为技术不成熟阶段,术者后期完成的62例定义为技术成熟阶段。

结果

围手术期8例出现了并发症,并发症发生率为7.8%(8/102)。技术不成熟阶段并发症发生率为12.5%(5/40),明显高于技术成熟阶段的4.8%(3/62);出血性并发症发生率为3.9%(4/102),缺血性并发症发生率为3.9%(4/102);8例中,1例导丝头刺破远端分支血管,1例支架近端刺破脉络膜前动脉,2例术后出血考虑为过度灌注、抢救无效死亡,3例穿支卒中,1例穿支短暂性脑缺血发作(TIA)。死亡2例(2.0%),重残1例,轻度残障3例,无神经系统功能缺损2例。

结论

Wingspan支架治疗症状性大脑中动脉重度狭窄风险相对较高,但对于手术操作熟练、适应证把握严格的术者,Wingspan支架成形术是相对安全的。

Objective

To retrospectively record the periprocedural complications of stenting with Gateway-Wingspan system for symptomatic middle cerebral artery high-grade stenosis,analyze the reason and discuss the prevention methods.

Methods

We reviewed the medical records of Wingspan stenting for 102 cases with symptomatic middle cerebral artery high-grade stenosis from February 2008 to May 2012 and recorded all the periprocedural adverse events.All of the complications were analyzed.The initial 40 cases completed by the operators were taken into the unskilled stage and the rest 62 cases were taken into the skilled stage.

Results

Eight complications were recorded and the rate was 7.8%(8/102).The rate of complications in the unskilled stage was 12.5%(5/40)which was obviously higher than the complications rate 4.8%(3/62)in the skilled stage.the rate of hemorrhage complications was 3.9%(4/102)which was equal to the rate of ischemic complications.The complications consisted of 2 artery perforation,2 intracranial hemorrhage because of hyperperfusion injury,3 perforator stroke and 1 TIA.Of those complications,2 cases with intracranial hemorrhage were dead,1 case got serious disability as a sequel,3 cases had slight disability and the others had no permanent neurological deficits.

Conclusions

The treatment of symptomatic middle cerebral artery high-grade stenosis with Gateway-wingspan system was at a relatively high-risk.But if the procedures were operated by the skilled operator,the treatment was relatively safe.

表1 8例出现围手术期并发症患者的临床资料
1
Huang YN,Gao S,Li SW,et al.Vascular lesions in Chinese patients with transient ischemic Attacks.neurology,1997,48:524-525.
2
倪俊,高山,崔丽英.症状性大脑中动脉狭窄的预后和影响因素.中华老年心脑血管病杂志,2009,11:955-958.
3
Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke.Results of an international randomized trial.The EC/IC Bypass Study Group.N Engl J Med,1985,313:1191-1200.
4
Bose A,Hartmann M,Henkes H,et al.A novel,self-expanding,nitinol stent in medically refractory intracranial atherosclerotic stenoses:the Wingspan study.Stroke,2007,38:1531-1537.
5
李天晓,李钊硕,王子亮,等.Wingspan支架治疗症状性颅内动脉粥样硬化严重狭窄的临床研究.中华放射学杂志,2010,44:969-974.
6
Chimowitz MI,Lynn MJ,Derdeyn CP,et al.Stenting versus aggressive medical therapy for intracranial arterial stenosis.N Engl J Med,2011,365:993-1003.
7
王子亮,徐浩文,李天晓,等.颅内动脉硬化狭窄Wingspan支架成形穿支卒中的临床研究.中华放射学杂志,2011,45:1054-1058.
8
Chimowitz MI,Lynn MJ,Howlett-Smith H,et al.Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.N EnglJ Med,2005,352:1305-1316.
9
Fiorella D,Levy EI,Turk AS,et al.US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease:periprocedural results.Stroke,2007,38:881-887.
10
Kurre W,Berkefeld J,Brassel F,et al.In-hospital complication rates after stent treatment of 388 symptomatic intracranial stenoses results from the INTRASTENT multicentric registry.Stroke,2010,41:494-498.
11
Miao ZR,Feng L,Li S,et al.Treatment of symptomatic middle cerebral artery stenosis with balloon-mounted stents:long-term follow-up at a single center.Neurosurgery,2009,64:79-85.
12
许斌,史怀章,徐善才,等.颅内支架成形术出血并发症的原因和防治.中华放射学杂志,2012,46:1054-1068.
13
Nahab F,Lynn MJ,Kasner SE,et al.Risk factors associated with major cerebrovascular complications after intracranial stenting.Neurology,2009,72:2014-2019.
14
Lee TH,Kim DH,Lee BH,et al.Preliminary results of endovascular stent-assisted angioplasty for symptomatic middle cerebral artery stenosis.AJNR Am J Neuroradiol,2005,26:166-174.
15
Aliabadi D,Tilli FV,Bowers TR,et al.Incidence and angiographic predictors of side branch occlusion following high-pressure intracoronary stenting.Am J Cardiol,1997,80:994-997.
16
Lanzino G,Fessler RD,Miletich RS,et al.Angioplasty and stenting of basilar artery stenosis:technical case report.Neurosurgery,1999,45:404-408.
17
Jiang WJ,Srivastava T,Gao F,et al.Perforator stroke after elective stenting of symptomatic intracranial stenosis.Neurology,2006,66:1868-1872.
[1] 马桥桥, 张传开, 郭开今, 蒋涛, 王子豪, 刘勇, 郝亮. 可降解止血粉减少初次全膝关节置换术失血量的研究[J]. 中华关节外科杂志(电子版), 2024, 18(05): 585-589.
[2] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[3] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[4] 许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[5] 张钊, 骆成玉, 张树琦, 何平, 李旭斌. 不同术式治疗早期乳腺癌的效果及并发症发生率、复发率比较[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 494-497.
[6] 曾繁利, 齐秩凯, 杨贺庆. 两种经Glisson蒂鞘解剖路径肝切除术治疗原发性肝癌的肿瘤学疗效及风险比对[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 525-527.
[7] 向辉, 贾晓斌, 全卫涛. 真空辅助乳腺微创旋切术治疗乳腺纤维瘤的效果及并发症观察[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 528-530.
[8] 王维花, 王楠, 乔庆, 罗红. 完全腹腔镜右半结肠癌切除术两种腔内消化道重建方案对比研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 574-577.
[9] 刘明辉, 葛方明. MRI 对腹股沟疝修补术后患者早期并发症的评估价值研究[J]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 579-583.
[10] 马振威, 宋润夫, 王兵. ERCP胆道内支架与骑跨十二指肠乳头支架置入治疗不可切除肝门部胆管癌疗效的Meta分析[J]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 807-812.
[11] 李澄清, 郭文毅, 王磊. 腹腔镜保留脾脏胰体尾切除术:微创胰腺外科的合理决策[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 620-624.
[12] 罗柳平, 吴萌萌, 陈欣磊, 林科灿. 胰腺全系膜切除在胰头癌根治术中的应用价值[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 651-656.
[13] 韩青雷, 丛赟, 李佳隆, 邵英梅. 术前减黄方式对壶腹周围癌胰十二指肠切除术后并发症的影响[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 665-669.
[14] 冯熔熔, 苏晓乐, 王利华. 慢性肾脏病患者并发心血管疾病相关生物标志物研究进展[J]. 中华肾病研究电子杂志, 2024, 13(05): 273-278.
[15] 王璇, 娜扎开提·尼加提, 雒洋洋, 蒋升. 皮肤晚期糖基化终末产物浓度与2型糖尿病微血管并发症的相关性[J]. 中华临床医师杂志(电子版), 2024, 18(05): 447-454.
阅读次数
全文


摘要